Biodexa Pharmaceuticals (BDRX) Interest Income - Deposits (2019 - 2022)
Biodexa Pharmaceuticals (BDRX) posted Interest Income - Deposits of $8210.5 for Q4 2022, down 5.16% sequentially from $8657.1 in Q3 2022.
Biodexa Pharmaceuticals (BDRX) Interest Income - Deposits (2019 - 2022) Analysis & Trends
Biodexa Pharmaceuticals has reported Interest Income - Deposits for 3 years, with the latest figure at $8210.5 in Q4 2022.
- Quarterly Interest Income - Deposits changed N/A year-over-year to $8210.5 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $19412.6 (changed N/A YoY) and the FY2025 annual result came in at $118665.9, down 47.47% from the prior year.
- Interest Income - Deposits slipped to $8210.5 in Q4 2022 per BDRX's latest filing, from $8657.1 in the prior quarter.
- Over five years, Interest Income - Deposits peaked at $8657.1 in Q3 2022 and troughed at $1259.3 in Q3 2020.
- A 3-year average of $4853.1 and a median of $4748.1 in 2019 frame the typical range for Interest Income - Deposits.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Deposits (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Biodexa Pharmaceuticals | 64,325.41 | -11.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 8,210.50 |
| Sep 14, 2022 | 8,657.08 |
| Sep 10, 2020 | 1,259.28 |
| Dec 31, 2019 | 1,285.72 |